Combination of KIT and FLT3‐ITD mutation status with minimal residual disease levels guides treatment strategy for adult patients with inv(16) acute myeloid leukemia in first complete remission
Sign Up to like & getrecommendations! Published in 2022 at "Hematological Oncology"
DOI: 10.1002/hon.3015
Abstract: Although several studies have investigated the benefits of allogeneic hematopoietic stem cell transplantation (allo‐HSCT) for patients with inv (16) acute myeloid leukemia (AML) in first complete remission (CR1) individually stratified by KIT or FMS‐like tyrosine… read more here.
Keywords: combination; flt3 itd; allo hsct; mutation status ... See more keywords
Association between squamous cell carcinoma antigen level and EGFR mutation status in Chinese lung adenocarcinoma patients
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.24613
Abstract: To investigate the association between squamous cell carcinoma antigen (SCCAg) level and epidermal growth factor receptor (EGFR) mutation status in Chinese lung adenocarcinoma patients. read more here.
Keywords: cell carcinoma; mutation status; squamous cell; carcinoma antigen ... See more keywords
Identification of IDH and TERTp mutation status using 1H‐MRS in 112 hemispheric diffuse gliomas
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Magnetic Resonance Imaging"
DOI: 10.1002/jmri.26964
Abstract: There is a growing interest in noninvasively defining molecular subsets of hemispheric diffuse gliomas based on the isocitrate dehydrogenase (IDH) and telomerase reverse transcriptase gene promoter (TERTp) mutation status, which correspond to distinct tumor entities,… read more here.
Keywords: mutation status; hemispheric diffuse; tertp mutation; diffuse gliomas ... See more keywords
Radiomics signature of brain metastasis: prediction of EGFR mutation status
Sign Up to like & getrecommendations! Published in 2021 at "European Radiology"
DOI: 10.1007/s00330-020-07614-x
Abstract: To predict epidermal growth factor receptor (EGFR) mutation status in lung adenocarcinoma using MR-based radiomics signature of brain metastasis and explore the optimal MR sequence for prediction. Data from 52 patients with brain metastasis from… read more here.
Keywords: mutation status; radiomics signature; egfr mutation; signature ... See more keywords
Predictive models for patients with lung carcinomas to identify EGFR mutation status via an artificial neural network based on multiple clinical information
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Cancer Research and Clinical Oncology"
DOI: 10.1007/s00432-019-03103-x
Abstract: Purpose Epidermal growth factor receptor (EGFR) mutation testing has several limitations. Therefore, we built predictive models to determine the EGFR mutation status of patients and guide therapeutic decision-making. Methods We collected data from 320 patients… read more here.
Keywords: model; model auroc; egfr mutation; mutation status ... See more keywords
Clinical assessment of the GNAS mutation status in patients with intraductal papillary mucinous neoplasm of the pancreas
Sign Up to like & getrecommendations! Published in 2019 at "Surgery Today"
DOI: 10.1007/s00595-019-01797-7
Abstract: Intraductal papillary mucinous neoplasm (IPMN) of the pancreas is characterized by cystic dilation of the pancreatic duct, caused by mucin hypersecretion, with slow progression via the adenoma–carcinoma sequence mechanism. Mutation of GNAS at codon 201… read more here.
Keywords: papillary mucinous; mutation status; gnas mutation; intraductal papillary ... See more keywords
The Long-To-Short-Axis Ratio and Multifocality are Associated With TP53 Mutation Status in Surgically Resected Hepatocellular Carcinomas.
Sign Up to like & getrecommendations! Published in 2018 at "Academic radiology"
DOI: 10.1016/j.acra.2018.04.021
Abstract: RATIONALE AND OBJECTIVES In hepatocellular carcinoma (HCC), the tumor protein 53 (TP53) gene is frequently mutated and the mutations have been associated with poor prognosis. We aim to retrospectively identify the relationship between TP53 mutation… read more here.
Keywords: tp53 mutation; mutation status; ratio; multifocality ... See more keywords
Prediction of IDH Mutation Status in High-grade Gliomas Using DWI and High T1-weight DSC-MRI.
Sign Up to like & getrecommendations! Published in 2021 at "Academic radiology"
DOI: 10.1016/j.acra.2021.02.002
Abstract: RATIONALE AND OBJECTIVES We aimed to evaluate the diagnostic performance of diffusion-weighted imaging (DWI) and dynamic susceptibility contrast-enhanced (DSC) magnetic resonance imaging (MRI) parameters in the noninvasive prediction of the isocitrate dehydrogenase (IDH) mutation status… read more here.
Keywords: mutation status; idh mutation; mri; idh ... See more keywords
Magnetic resonance imaging criteria for prediction of isocitrate dehydrogenase (IDH) mutation status in patients with grade II-III astrocytoma and oligodendroglioma
Sign Up to like & getrecommendations! Published in 2021 at "Clinical Neurology and Neurosurgery"
DOI: 10.1016/j.clineuro.2021.106745
Abstract: BACKGROUND IDH mutation status is an important prognostic marker for glial tumors, which is detected immunohistochemically after surgery. Since this method is invasive, easy and noninvasive magnetic resonance imaging (MRI) methods have recently been used… read more here.
Keywords: mutation status; grade iii; iii astrocytoma; idh mutation ... See more keywords
Impact of experimental design on PET radiomics in predicting somatic mutation status.
Sign Up to like & getrecommendations! Published in 2017 at "European journal of radiology"
DOI: 10.1016/j.ejrad.2017.10.009
Abstract: PURPOSE PET-based radiomic features have demonstrated great promises in predicting genetic data. However, various experimental parameters can influence the feature extraction pipeline, and hence, Here, we investigated how experimental settings affect the performance of radiomic… read more here.
Keywords: pet; radiomic features; mutation status; somatic mutation ... See more keywords
Brain metastasis in epithelial ovarian cancer by BRCA1/2 mutation status.
Sign Up to like & getrecommendations! Published in 2019 at "Gynecologic oncology"
DOI: 10.1016/j.ygyno.2019.05.004
Abstract: OBJECTIVE To evaluate clinical outcomes of patients with BRCA-associated ovarian cancer who developed brain metastases (BM). METHODS Patients with epithelial ovarian, fallopian tube, and primary peritoneal cancer (EOC) and BM, treated at a single institution… read more here.
Keywords: status; mutation status; ovarian cancer; brain ... See more keywords